For research and educational purposes only. Not medical advice.
Lonapegsomatropin Reference
Educational, not medical advice reference for Lonapegsomatropin: GH Release, Hormonal; regulatory status, evidence posture, source review, and schedule notes…
Reference summary
Lonapegsomatropin is a label-verified long-acting somatropin product for pediatric GHD. pepSmart surfaces label-reference content only.
- Categories
- GH Release, Hormonal
- Aliases
- Skytrofa, Lonapegsomatropin-tcgd, Long-acting pediatric somatropin
- Evidence posture
- human — Pediatric prescription human growth hormone product. WADA-prohibited at all times under category S2. Possession or distribution outside an FDA-approved indication is restricted by the Anabolic Steroid Control Act.
- Regulatory status
- FDA-approved prescription medication (Skytrofa). Indicated for pediatric growth hormone deficiency. WADA-prohibited under category S2 at all times. Distribution and possession outside an approved indication is restricted under the United States Anabolic Steroid Control Act.
- Content review status
- label verified